Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Samsara Opportunity Fund Gp, Llc

Over the trailing 90 days, Samsara Opportunity Fund Gp, Llc (10% Owner at Kalaris Therapeutics, Inc.) bought $1.2M of stock in KLRS, per 4 SEC Form 4 transactions.

Role
10% Owner
Companies
KLRS
Window
Trailing 90 days · 4 transactions · CIK 2086456
Net activity
+$1.2M ($1.2M bought · $0 sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
KLRSKalaris Therapeutics, Inc.4$1.2M$1.2M

Transactions (4)

DateSymbolTypeSharesValueDescription
2026-05-20KLRSBuy4.5K$0Other acquisition or disposition
2026-05-20KLRSBuy14.9K$0Other acquisition or disposition
2026-05-20KLRSSell66.9K$0Other acquisition or disposition
2026-05-20KLRSBuy244.3K$1.2MOpen market or private purchase

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Samsara's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free